If you could vote on Brexit now which option would you choose?

Zero Johnson & Johnson COVID-19 vaccine doses set to ship next week as production holdup lingers

Johnson & Johnson’s COVID-19 vaccine ran into a big setback in late March when U.S. officials paused the rollout to investigate rare blood clots. While that issue has been resolved with a new warning about the rare risk, the company’s shot is running into another type of pause—a lack of supply. The federal government doesn’t plan to ship any J&J COVID-19 vaccine doses to states next week as production holdups linger at J&J’s manufacturing partner Emergent BioSolutions, CDC weekly distribution data show. Weeks ago, workers at Emergent’s plant in Baltimore ruined up to 15 million doses of the J&J shot, triggering a controversy for the contract manufacturer that ended up with J&J in charge of the key plant. Meanwhile, the feds and Emergent have halted production there as the contract manufacturer works through a laundry list of issues highlighted by FDA investigators during a recent site visit.

FiercePharma - May 14, 2021

View the full story here: https://www.fiercepharma.com/pharma/zero-johnson-johnson-covid-19-vaccine-doses-set-to-ship-next-week-as-production-holdup